Brand Name
Motofen
Generic Name
Difenoxin
View Brand Information FDA approval date: April 11, 2017
Classification: Cholinergic Muscarinic Antagonist
Form: Tablet
What is Motofen (Difenoxin)?
MOTOFEN® is indicated as adjunctive therapy in the management of acute nonspecific diarrhea and acute exacerbations of chronic functional diarrhea.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment